Molecular Docking studies of Apigenin, Kaempferol, and Quercetin as potential target against spike receptor protein of SARS COV

COVID-19 has been categorized as a pandemic in early 2020 and is known to cause by Severe Acute Respiratory Syndrome Coronavirus (SARS–CoV2). Numerous investigators and people in the scientific community are trying to find a superlative way to avert and cure the ailment by using phytochemicals. Abundant studies have revealed that flavonoids can be very operative in averting virus-mediated infection. The purpose of this study was to accomplish molecular docking studies among plant-derived flavonoids (Apigenin, Kaempferol, and Quercetin) and spike receptor (PDB ID: 2AJF) protein of coronavirus. Pyrx virtual screening tool and biovia discovery studio visualizer were utilized in the current molecular docking investigations. Outcomes of docking studies exposed that selected phytochemicals have interacted with targeted spike receptor protein with binding energies in the range of -6.3 to -7.3 kcal. In conclusion among the various selected ligands, quercetin may be a better inhibitor for the deactivation of SARS-Coronavirus.

[1]  J. Kaur,et al.  Molecular Evolution of Severe Acute Respiratory Syndrome Coronavirus 2: Hazardous and More Hazardous Strains Behind the Coronavirus Disease 2019 Pandemic and Their Targeting by Drugs and Vaccines , 2021, Frontiers in Cellular and Infection Microbiology.

[2]  Gurpreet Kaur Bhatia,et al.  Efficacy and Safety of New and Emerging Drugs for COVID-19: Favipiravir and Dexamethasone , 2021, Current Pharmacology Reports.

[3]  A. Sharma,et al.  Mechanistic insight into anti-COVID-19 drugs: recent trends and advancements , 2021, 3 Biotech.

[4]  S. Sood,et al.  Ayurveda and Allopathic Therapeutic Strategies in Coronavirus Pandemic Treatment 2020 , 2020, Current Pharmacology Reports.

[5]  D. Silveira,et al.  COVID-19: Is There Evidence for the Use of Herbal Medicines as Adjuvant Symptomatic Therapy? , 2020, Frontiers in Pharmacology.

[6]  Manoj Kumar,et al.  COVID-19 Pandemic: from Molecular Biology, Pathogenesis, Detection, and Treatment to Global Societal Impact , 2020, Current Pharmacology Reports.

[7]  H. Ahmed,et al.  Investigation of Some Antiviral N-Heterocycles as COVID 19 Drug: Molecular Docking and DFT Calculations , 2020, International journal of molecular sciences.

[8]  Hai-Feng Ji,et al.  A search for medications to treat COVID-19 via in silico molecular docking models of the SARS-CoV-2 spike glycoprotein and 3CL protease , 2020, Travel Medicine and Infectious Disease.

[9]  J. Opferman,et al.  Identification of substituted 5-membered heterocyclic compounds as potential anti-leukemic agents. , 2019, European journal of medicinal chemistry.

[10]  Arthur J. Olson,et al.  AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading , 2009, J. Comput. Chem..